Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin and Tadalafil Combination for LUTS/BPH and ED
NCT02862483Phase 3Unknown
- Sponsor
- Ildong Pharmaceutical Co Ltd
- Start
- Mar 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tamsulosin in benign prostatic hyperplasia (BPH) and erectile dysfunction (ED) (2 arms), sponsored by Ildong Pharmaceutical Co Ltd. Primary endpoints: International Prostate Symptom Score at 12 weeks and International Index of Erectile Function - Erectile Function Domain at 12 weeks. Status: unknown.
02
Drugs
tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT02862483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02862483.